Molecular Biology of the Cell track citations

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

MBC in Press, published online ahead of print May 29, 2003
Mol. Biol. Cell 10.1091/mbc.E03-04-0239

A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-04-0239v1
14/9/3519    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maile, L. A.
Right arrow Articles by Clemmons, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maile, L. A.
Right arrow Articles by Clemmons, D. R.

Submitted on April 17, 2003
Accepted on May 15, 2003

The association between integrin associated protein and SHPS-1 regulates IGF-I receptor signaling in vascular smooth muscle cells

Laura A. Maile, Jane Badley-Clarke, and David R. Clemmons*

* Corresponding author. E-mail address: endo{at}med.unc.edu.

Growth factor signaling is usually analyzed in isolation without considering the effect of ligand occupancy of transmembrane proteins other than the growth factor receptors themselves. In smooth muscle cells (SMCs) the transmembrane protein SHPS-1 has been shown to be an important regulator of insulin-like growth factor-I (IGF-I) signaling. SHPS-1 is phosphorylated in response to IGF-I leading to recruitment of the tyrosine phosphatase, SHP-2. Subsequently, SHP-2 is transferred to IGF-I receptor (IGF-IR) and regulates the duration of IGF-IR phosphorylation. Whether ligand occupancy of SHPS-1 influences SHPS-1 phosphorylation or SHP-2 recruitment thereby altering growth factor signaling is unknown. Previous studies have shown that integrin associated protein (IAP) associates with SHPS-1. We undertook these studies to determine if this interaction controlled SHPS-1 phosphorylation and/or SHP-2 recruitment and thereby regulated IGF-I signaling.

Disruption of IAP-SHPS-1 binding, using an IAP mAb or cells expressing mutant forms of IAP that did not bind to SHPS-1, inhibited IGF-I stimulated SHPS-1 phosphorylation and SHP-2 recruitment. This was associated with a lack of SHP-2 transfer to IGF-IR and sustained receptor phosphorylation. This resulted in an inability of IGF-I to stimulate sustained MAP kinase activation, cell proliferation and cell migration. The effect was specific for IGF-I since disruption of the IAP/SHPS-1 interaction had no effect on PDGF stimulated SHPS-1 phosphorylation or cell migration.

In summary, our results show that 1) ligand occupancy of SHPS-1 is a key determinant of its ability to be phosphorylated following IGF-I stimulation and 2) the interaction between IAP and SHPS-1 is an important regulator of IGF-I signaling since disruption of the results in impaired SHP-2 recruitment and subsequent inhibition of IGF-I stimulated cell proliferation and migration.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
G. Xi, X. Shen, and D. R. Clemmons
p66shc Negatively Regulates Insulin-Like Growth Factor I Signal Transduction via Inhibition of p52shc Binding to Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Leading to Impaired Growth Factor Receptor-Bound Protein-2 Membrane Recruitment
Mol. Endocrinol., September 1, 2008; 22(9): 2162 - 2175.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. A. Maile, B. E. Capps, E. C. Miller, L. B. Allen, U. Veluvolu, A. W. Aday, and D. R. Clemmons
Glucose Regulation of Integrin-Associated Protein Cleavage Controls the Response of Vascular Smooth Muscle Cells to Insulin-Like Growth Factor-I
Mol. Endocrinol., May 1, 2008; 22(5): 1226 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Y. Lee, D. A. Weber, O. Laur, E. A. Severson, I. McCall, R. P. Jen, A. C. Chin, T. Wu, K. M. Gernet, and C. A. Parkos
Novel Structural Determinants on SIRP{alpha} that Mediate Binding to CD47
J. Immunol., December 1, 2007; 179(11): 7741 - 7750.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Edderkaoui, P. Hong, J. K. Lee, S. J. Pandol, and A. S. Gukovskaya
Insulin-like Growth Factor-I Receptor Mediates the Prosurvival Effect of Fibronectin
J. Biol. Chem., September 14, 2007; 282(37): 26646 - 26655.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. L. Johansen and E. J. Brown
Dual Regulation of SIRP{alpha} Phosphorylation by Integrins and CD47
J. Biol. Chem., August 17, 2007; 282(33): 24219 - 24230.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. C. Miller, B. E. Capps, R. R. Sanghani, D. R. Clemmons, and L. A. Maile
Regulation of IGF-I Signaling in Retinal Endothelial Cells by Hyperglycemia
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3878 - 3887.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Endocr. Rev., February 1, 2007; 28(1): 20 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. A. Maile, W. H. Busby, K. Sitko, B. E. Capps, T. Sergent, J. Badley-Clarke, Y. Ling, and D. R. Clemmons
The Heparin Binding Domain of Vitronectin Is the Region that Is Required to Enhance Insulin-Like Growth Factor-I Signaling
Mol. Endocrinol., April 1, 2006; 20(4): 881 - 892.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Kwon, Y. Ling, L. A. Maile, J. Badley-Clark, and D. R. Clemmons
Recruitment of the Tyrosine Phosphatase Src Homology 2 Domain Tyrosine Phosphatase-2 to the p85 Subunit of Phosphatidylinositol-3 (PI-3) Kinase Is Required for Insulin-Like Growth Factor-I-Dependent PI-3 Kinase Activation in Smooth Muscle Cells
Endocrinology, March 1, 2006; 147(3): 1458 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
Y. Ling, L. A. Maile, J. Lieskovska, J. Badley-Clarke, and D. R. Clemmons
Role of SHPS-1 in the Regulation of Insulin-like Growth Factor I-stimulated Shc and Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells
Mol. Biol. Cell, July 1, 2005; 16(7): 3353 - 3364.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kapur, S. Mohan, D. J. Baylink, and K.-H. W. Lau
Fluid Shear Stress Synergizes with Insulin-like Growth Factor-I (IGF-I) on Osteoblast Proliferation through Integrin-dependent Activation of IGF-I Mitogenic Signaling Pathway
J. Biol. Chem., May 20, 2005; 280(20): 20163 - 20170.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Ling, L. A. Maile, J. Badley-Clarke, and D. R. Clemmons
DOK1 Mediates SHP-2 Binding to the {alpha}V{beta}3 Integrin and Thereby Regulates Insulin-like Growth Factor I Signaling in Cultured Vascular Smooth Muscle Cells
J. Biol. Chem., February 4, 2005; 280(5): 3151 - 3158.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. R. Clemmons and L. A. Maile
Interaction between Insulin-Like Growth Factor-I Receptor and {alpha}V{beta}3 Integrin Linked Signaling Pathways: Cellular Responses to Changes in Multiple Signaling Inputs
Mol. Endocrinol., January 1, 2005; 19(1): 1 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. A. Maile and D. R. Clemmons
Integrin-Associated Protein Binding Domain of Thrombospondin-1 Enhances Insulin-Like Growth Factor-I Receptor Signaling in Vascular Smooth Muscle Cells
Circ. Res., November 14, 2003; 93(10): 925 - 931.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2003 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.